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The  major  interest  of our  laboratory  in  recent  years  has  been  the  isolation  of 
components of Bordetella pertussis and the study of their effects. One of these compo- 
nents, lymphocytosis-promoting factor (LPF),  1 has been purified to homogeneity (1). 
LPF  is  responsible  for  the  lymphocytosis observed  in  a  number  of animals  after 
injection of phase I Bordetellapertussis. Moreover, it induces hypoglycemia and sensitizes 
mice to the lethal effects of histamine.  In  vitro, LPF is  a  potent  mitogen for both 
mouse and human lymphocytes (2, 3). It is known, at least in mice, that LPF is a B- 
dependent  T  mitogen.  Hence,  all  the  proliferating  cells  in  LPF  cultures  are  T 
lymphocytes, but  T  cells  can  only  respond  to  LPF  in  the  presence  of helper  B 
lymphocytes  (4).  In  vitro  culture  of lymphocytes  with  LPF  also  results  in  the 
production  of cytotoxic  effector  lymphocytes  with  specificity  for  allogeneic  and 
syngeneic tumor cells as well as allogeneic normal cells (5). 
The last step in the purification of LPF involved gel filtration on Sephadex G-150 
columns. Three protein peaks were detected after elution. LPF was recovered in the 
first  included peak, whereas the excluded peak contained the hemagglutinin  (HA) 
but no LPF activity. We now report that, in addition to HA, a potent mitogen distinct 
from LPF is also present in this fraction excluded from G-150. In contrast with LPF, 
this mitogen induces the proliferation of mouse B lymphocytes, but not T cells. Hence 
this substance is termed pertussis B mitogen (PBM). PBM is also mitogenic for human 
peripheral blood lymphocytes and cord blood lymphocytes. Moreover, it is a  poly- 
clonal activator for both mouse and human lymphocytes in vitro. 
Materials and Methods 
Mice.  CBA/J,  BALB/c,  C3H/HeJ,  and  DBA/2J  mice were  obtained  from The Jackson 
Laboratory  (Bar Harbor, Maine). CBA/N  mice were bred in this department  from National 
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Institutes of Health stock, whereas conventional and germfree CD-1  animals were  purchased 
from Charles River Breeding Laboratories (Wilmington,  Mass.). Unless otherwise stated, female 
CBA/J  mice,  8-14  wk  of age,  were  employed  for  all  experiments.  TxB  mice  were  adult 
thymectomized, irradiated, and reconstituted with  14- to  16-d fetal liver cells  as  previously 
described (6). 
Mouse Lymphocyte  Cultures.  Lymphocytes from spleen, peripheral lymph node, bone marrow, 
and  thymus  were  prepared  as  described  (4)  and  cultured  in  RPMI-1640  (Grand  Island 
Biological  Co., Grand Island, N. Y.) supplemented with 5% heat-inactivated fetal calf serum 
(FCS)  (Microbiological Associates,  Walkersville, Md.),  100 U/ml penicillin, and  100 #g/ml 
streptomycin unless specified. 
For determination of DNA  synthesis, 5  ×  105  lymphocytes in 0.25  ml of medium were 
cultured in microtiter plates (IS-FB 96;  Linbro Chemical Co.,  Harden, Conn.), pulsed with 
[ZH]thymidine, harvested, and counted as described (4). The [3H]thymidine incorporation was 
expressed  as the mean counts per minute ×  10  -3 ",- SD of triplicate samples. 
For assay of antibody-forming cells, a  modified method of Nilsson et al.  was adopted  (7). 
Briefly,  triplicate cultures containing 10 ×  10  e lymphocytes in  1 ml of RPMI-5% FCS were 
incubated with or without mitogens in 10- ×  35-mm plastic petri dishes (Falcon Labware, Div. 
of Becton, Dickinson & Co., Oxnard, Calif.) at  37°C. The dishes  were  placed on a  rocking 
platform (8 oscillations/min) in an atmosphere of 83% N2,  10% CO2, and 7% 02. After 48 h of 
incubation, cells from triplicate cultures were scraped off the dishes, pooled, and washed three 
times in medium. Antibody-forming cells were  enumerated by a  modified hemolytic plaque 
assay (7) using sheep erythrocytes and trinitrophenyl (TNP)-conjugated sheep erythrocytes (8). 
Human  Lymphocyte  Cultures.  Heparinized venous blood was obtained from normal healthy 
donors.  Blood  mononuclear cells  were  collected by a  modification of Boyum's method  (9). 
Briefly, the blood was mixed with an equal volume of sterile saline. 2 vol of this blood-saline 
solution was  layered on  1 vol  of Ficoll-Conray solution prepared by mixing 1 vol of 33.4% 
Conray (meglumine iothalamate; Mallinckrodt Inc., St.  Louis, Mo.)  to  2.4 vol of 9%  Ficoll 
(Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N.J.).  After centrifuging for 
30 rain at 4°C, cells were collected from the interface and washed three times with serum-free 
RPMI-1640. When assayed  for proliferative responses,  triplicate cultures of 1.25 ×  105 cells in 
0.25  ml of RPMI-1640-5 % FCS were  dispensed in Linbro microtiter plates (IS-FB 96)  and 
incubated in 5% CO2, 95% air at 37°C for  120 h. The cells were  pulsed and processed  as for 
mouse cells. Cord blood was processed  in a similar fashion. 
For polyclonal activation, the procedure of Fauci and Pratt  (10) was  employed. Human 
peripheral  blood  lymphocytes  (HPBL)  were  resuspended  to  2  ×  10n/ml  in  RPMI-1640 
supplemented with  10%  fresh  pooled  AB  serum  obtained from  healthy  donors.  Triplicate 
cultures of 2  ×  10  ~ HPBL were  incubated with the appropriate mitogens in  12-  ×  75-mm 
plastic tubes at 37°C in a humid atmosphere of 5% CO2, 95% air. At 120 h cells from triplicate 
cultures were pooled and washed three times with phosphate-buffered saline, pH 7.2. Antibody- 
forming cells against sheep erythrocytes or TNP-conjugated sheep erythrocytes were assayed as 
described for mouse cells. 
Mitogens.  LPF was purified from the culture supernatant fluids of phase I Bordetella pertussis, 
strain 114, as described (1). Briefly, solid  (NH4)2SO4 was added to culture supernates to 90% 
saturation at 4°C and pH 6.4. Then the (NH4)2SO4 precipitates were collected and dialyzed 
against water. The water-insoluble material was resuspended in 0.1 M Tris-0.5M NaCI, pH 10. 
Any insoluble material was discarded. The soluble fraction was loaded on a CsCI gradient of 
densities 1.5, 1.3, 1.25, and 1.2 and after centrifuging  at 50,000 g for 3.5 h, the load volume was 
removed and passed  through  Sephadex  G-150.  Three  protein peaks  were  eluted.  LPF was 
isolated and purified from the first  included peak, whereas PBM and HA were  found in the 
excluded peak. Optimal concentrations of mitogens per culture of mouse lymphocytes are as 
follows:  LPF,  0.5  #g;  PBM,  0.5  #g;  phytohemagglutinin-P (PHA-P)  (Difco  Laboratories, 
(Detroit, Mich.), 0.18 #1; concanavalin  A (Con A) (Pharmacia Fine Chemicals), 0.5 ~g. In early 
experiments, lipopolysaccharide (LPS)  prepared from B. pertussis  by the method Nakase et al. 
(11) was used at 5 ~g/culture whereas later experiments employed S. typhosa LPS (phenol-water 
preparation; Difco Laboratories) at  1.25 pg/culture. 
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5.0  #g/culture.  PHA-P was  used  at  1.25 /.tl and  Con  A  at  1.25 /xg  per  culture.  Various 
concentrations of pokeweed mitogen (PWM)  (Difco Laboratories), ranging from 0.16 to 0.63 
#1 were added per culture. For assaying antibody-forming  cells, a wide range of concentrations 
of PBM, PWM, and LPS were employed (see Results). 
Immunofluorescence.  Mouse lymphocytes bearing  surface immunoglobulins  (slg) were detected 
by fluorescein-conjugated  F(ab')2 fragments of goat anti-mouse IgG (N. L. Cappel Laboratories 
Inc., Cochranville, Pa.) as described (4). The final dilution of the antisera was  1:10. 
Fractionation of Spleen Cells on Nylon Wool Columns.  Spleen cells were separated into a nylon- 
nonadherent, T-enriched fraction and a  nylon-adherent, B-enriched fraction on nylon wool 
(FT-242; Fenwall Laboratories, Inc., Morton Grove, II.) columns according to the methods of 
Julius et al. (12) and Handwerger and Schwartz (13) as described (4). Routinely, the nonad- 
herent fraction consisted of 27% and the adherent fraction 55% of the spleen cells loaded onto 
the column. Viability of both fractions was >97%. 
Lysis of Thy 1  ÷ Cells.  CBA/J spleen cells were incubated with a  1:8 dilution of anti-Thy 1.2 
antisera at  37°C  for 60  min, washed  once, and then treated  with  guinea pig complement 
(diluted 1:8, Grand Island Biological  Co.)  at 37°C for 30 min. The antisera was prepared by 
the method of Reif and Allen (14). 
Removal of Macrophages.  Macrophages were removed either by passage through Sephadex G- 
10 columns or incubation with carbonyl iron. The efficiency of depletion was monitored by 
esterase staining and latex ingestion. These procedures have been described in detail previously 
(4). 
Results 
Effect of Various Concentration of PBM on Lymphocytes  from Spleen, Peripheral Lymph Node, 
Bone Marrow, and Thymus.  5  ×  105 lymphocytes from various lymphoid tissues were 
cultured with increasing concentrations of PBM in a  total volume of 0.25 ml for 48 
h. These culture conditions were found to be optimal in preliminary experiments. As 
seen  in  Fig.  1.,  PBM,  when  used  at  a  concentration as  low  as  0.125  ptg/culture, 
induced a  marked increase in [3H]thymidine incorporation of splenic lymphocytes. 
Maximal  proliferative  response  was  reached  when  the  PBM  concentration  was 
increased to 0.5 #g/culture. Further increases in PBM concentrations did not induce 
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FiG.  I.  Mitogenic effect of PBM on lymphocytes from various lymphoid tissues, 5 X  105 ]ympho- 
cytes from spleen (×), peripheral lymph node (O), bone marrow (I), or thymus (&) in 0.25 ml were 
cultured with the indicated concentrations of PBM. At 48 h, triplicate cultures were harvested and 
[3H]thymidine incorporation expressed as mean counts per minute X 10  -a + SD. B  LYMPHOCYTE  MITOGEN  FROM  BORDETELLA  PERTUSSIS  78 
higher levels of proliferation. Peripheral lymph node cells were much less responsive 
than  spleen  cells,  and  the  maximal  response  was  obtained  only at  a  higher  PBM 
concentration of 1.5/~g/culture.  Bone marrow cells were slightly responsive to PBM 
whereas thymocytes were totally unresponsive:  similar findings were obtained when 
the time of incubation was extended. 
Morphologic studies showed  that  60-80%  of the  viable cells recovered from 48-h 
spleen cell cultures containing 0.5/tg PBM were blast cells. Moreover, the number of 
blast cells in PBM cultures correlated well with the level of [3H]thymidine incorpo- 
ration. 
Time-Course of PBM-induced Proliferation of Spleen Cells From CBA /J Mice.  Fig. 2 shows 
that a  significant level of [aH]thymidine incorporation occurs in spleen cell cultures 
containing PBM  at 24 h  of incubation.  When 0.5/.tg of PBM was used per culture, 
the  peak proliferative response was at  48  h.  Thereafter,  the  response decreased.  In 
cultures containing suboptimal concentrations of PBM (0.25/~g/culture),  the level of 
[aH]thymidine incorporation  also reached a  maximum at 48 h, but  did not start to 
decline until after 72 h  of incubation.  Therefore, 48 h  was chosen as the time period 
of culture for subsequent experiments. 
Effect  of FCS on the Mitogenicity  of PBM.  Because the  mitogenic effect of PBM  is 
routinely  assayed  in  cultures  supplemented  with  5%  heat-inactivated  FCS,  it  is 
conceivable that the mitogenic principle is a complex of PBM and serum components. 
Therefore, the proliferative response of spleen cells both in the presence and absence 
of serum was examined  (Fig.  3).  At suboptimal doses of PBM  (0.125  and 0.25 ktg/ 
culture), the [aH]thymidine incorporation was similar in both types of culture. When 
higher concentrations of PBM were used, the responses in serum-containing cultures 
were  slightly  higher  than  serum-free cultures.  This  may  be  a  result  of better  cell 
viability  in  the  former.  Nevertheless,  it  is  clear  that  serum  components  are  not 
necessary for PBM to exert its mitogenic effect. 
Response of Lymphocytes from  Various Mouse Strains to PBM.  To examine whether the 
activation of lymphocytes by PBM in vitro is a  result of earlier exposure to PBM or 
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Ftc.  2.  Time-course of PBM-induced proliferation of CBA/J spleen cells. 5 X  105 splenic lympho- 
cytes from CBA/J  mice were cultured in the presence of 0.75/xg (x--.--X),  0.5/~g (O  O), 0.25 
#g  (O----O),  or  0.125  #g  (x  x)  of  PBM  for  various  times.  Controls  contained  no  PBM 
(H).  Indicated are mean counts per minute x  10  -a +  SD of triplicate 0.25-ml cultures. M.-K.  HO,  S.  I.  MORSE,  AND  A.  S.  KONG  79 
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Fro.  3.  Effect of fetal calf serum on the stimulation of spleen cells by PBM. Indicated concentra- 
tions of PBM were added to 5 ×  105 spleen cells and cultured in the presence (O), or absence (O) of 
5% fetal calf serum for 48 h. Results are expressed as mean counts per minute ×  10  -8 ±  SD of 
triplicate samples. 
TABLE  I 
[aH] Thymidine  Incorporation by Spleen Cells from Different Mouse Strains in Response to PBM 
Experi-  Mouse strain 
ment 
Mitogen/cult  ure 
PBM,  PBM,  Con A,  LPS*  None 
0.25 #g  0.5 #g  0.5 #g 
cpm ×  10 -3 "4- SD 
BALB/c  46.4 ±  2.0  64.1 :t: 4.3  --  30.0 ±  3.5  0.9 ±  0 
nu+/nu  +  51.5 -1- 2.6  70.5 ±  8.0  --  34.5 :t: 5.1  3.1 :t: 0.3 
C3H/HeJ  24.3 ±  1.1  39.8 ±  2.0  --  9.9 ±  0.3  1.7 :t: 0 
DBA/2J  --  97.7 ±  4.6  154.1 :t: 0.4  42.5 ±  2.3  1.5 ±  0.5 
Normal CD-I  106.4 ±  10.8  129.8 ±  0.7  62.3 ±  7.2  98.4 ±  28.0  8.4 ±  1.3 
Axenic CD-1  134.9 ±  12.2  135.7  :l: 3.8  54.5 +  12.9  102.1  ±  12.9  3.6 ±  0.2 
CBA/J  68.7 ±  8.4  85.1 ±  3.9  125.8  ±  9.4  72.0 ±  6.7  2.8 ±  0.8 
CBA/N  43.2 ±  4.8  51.3 ±  7.3  93.8 ±  5.3  34.6 ±  0.6  0.3 ±  0 
* LPS in experiment  1 was isolated from B. pertussis and was used at 5 #g/culture whereas  1.25 #g of 5'. 
typhosa LPS from Difco Laboratories was used in experiment 2. 
other  cross-reactive  antigens,  the response  of spleen  lymphocytes  from  a  number  of 
mouse strains was assayed  (Table I). Lymphocytes  from normal  inbred mouse strains, 
such as BALB/c,  DBA/2J,  and  CBA/J  responded  well to PBM,  as did outbred  CD- 
1 animals.  Moreover,  axenic CD-1  mice were as reactive as their counterparts  raised 
under  conventional  conditions.  Therefore,  PBM  is a  nonspeeific  mitogen  for mouse 
lymphocytes. 
It  is  interesting  to  note  that  three  mouse  strains with  known  defects  in  immune 
functions  also  responded  to  PBM.  First,  spleen  cells  from  athymic  nude  mice  of 
BALB/c  background  proliferated  to  a  similar  extent  as  cells  from  BALB/c  mice 
indicating  that  the  proliferating  cells  in  PBM  cultures  were  not  T  lymphocytes. 
Moreover,  the stimulation  of lymphocytes  by PBM  could occur  in the absence of T 
cells. Secondly, C3H/HeJ  mice, which were low responders to the mitogenic effects of 
LPS  (15),  failed  to  respond  to  LPS  isolated  from  B.  pertussis,  but  were  markedly 80  B  LYMPHOCYTE  MITOGEN  FROM  BORDETELLA  PERTUSSIS 
activated by PBM. This suggested that the mitogenic principle in PBM was probably 
not LPS. Thirdly, when CBA/N mice with a  known defect in the maturation of B 
lymphocytes were used  (16), the  [3H]thymidine incorporation of their splenic lym- 
phocytes was approximately 60% that of cells from normal CBA/J  mice. However, 
the background incorporation of cultures containing no mitogen was also much lower 
than that of CBA/J cultures. Therefore, it appeared that the B cell defect in CBA/N 
mice had little effect on the proliferation of spleen cells after PBM stimulation. 
Nature of the Proliferating Lymphocytes.  The finding that spleen cells from congenitally 
athymic nude mice were responsive to PBM suggested that the lymphocytes stimulated 
by PBM were not T  cells. To delineate further the nature of cells activated by PBM, 
spleen cells from CBA/J mice were cultured with 0.5/.tg PBM for 48 h, recovered, 
and stained for slg by fluorescein-conjugated F(ab')2 fragments of rabbit anti-mouse 
IgG. 60-80% of the viable cells recovered were blast cells, and >95% of these blasts 
were slg  ÷ (Table II). Electron microscopic examination of blasts also revealed mor- 
phology  of plasmablasts  with  dilated  vesicular  rough  endoplasmic  reticulum  as 
described by Janossy et al. (17). Furthermore, when nylon-separated spleen cells were 
cultured with PBM, a proliferative response, similar in magnitude to that of unsepa- 
rated ceils, was only found associated with  the nylon-adherent fraction containing 
>85% slg  ÷ cells (Table III). 
PBM-induced Proliferation of Lymphocytes in the Absence of T Cells.  To confirm further 
that the response of B lymphoeytes to PBM is T  cell independent, spleen cells were 
TABLE II 
Detection of sIg on PBM-stimulated Spleen  Cells 
Cells/cul- 
ture*  Mitogen 
Cells recovered at 48 h 
Small 
lympho-  Blasts  slg+ 
blasts  cytes 
x  /&  x  /o  8 
20  PBM, 2 #g/ml  2.1  8.4  (80)$  8.0 
20  LPF, 2 Itg/ml  2.2  5.6  (72)  0.2 
20  None  3.6  0.3  (8)  0.2 
* 4 x  l0  s spleen cells in 2 ml were cultured in tubes with or without mitogens. 
At  48  h,  cells  from  five  tubes were pooled  and  stained  with  fluorescein- 
conjugated F(ab')2 fragments of goat anti-mouse IgG as described in Mate- 
rials and Methods. 
$ Number in parenthesis represents the percentage of viable cells  with mor- 
phology of blasts. 
TABLE III 
Proliferative Responses of Spleen Cells Separated on Nylon  Wool Columns 
Mitogen/cuhure 
Spleen cell 
PHA, 0.18 ~1  Con A, 0.5/tg  PBM, 0.5/~g  None 
Unseparated  21.8 +  2.7*  145.8 +  5.1  i46.1  +  6.6  7.9 +  0.7 
Nonadherent  18.8 ±  1.0  146.1 ±  15.3  1.7 "4- 0. I  0.1  ±  0.1 
Adherent  0.8 ±  0.1  4.6 ±  0.4  139.9 ±  1.5  0.7  +  0.4 
* Counts per minute ×  10  -a ±  SD of triplicate cultures of 0.5 X  106 CBA/J lymphocytes in 
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treated  with  Thy-I  antiserum  and  complement  before  culture.  Table  IV  indicates 
that such treatment  abolished the Con A  response but had no effect on stimulation by 
the B  cell mitogen, LPS, or by PBM.  This finding, together with the fact that  spleen 
cells from adult  thymectomized, X-irradiated  mice reconstituted  with fetal liver cells 
(TxB mice)  were responsive to  PBM  (Table V), suggested  that  PBM  was  mitogenic 
for mouse B  lymphocytes even in the absence of T  ceils. 
Effect of Macrophage Depletion on the Proliferative Response of Spleen Cells.  Macrophages 
have been implicated as accessory cells for some mitogens  (18-21).  To delineate their 
role  in  PBM-induced  proliferation,  spleen  ceils  were  cultured  before  and  after 
macrophages  were removed by either passage  through  Sephadex G-10 or incubation 
with  carbonyl  iron.  As  monitored  by  esterase  staining  and  latex  ingestion,  <1% 
macrophages  were  found  in  spleen  cell  populations  treated  by  either  procedure. 
Nevertheless,  treated  spleen  ceils  responded  to  PBM  as  well  as  their  untreated 
counterparts  (Table VI).  Hence,  macrophages  are not  required  for the activation of 
B  cells by PBM. 
Failure of Anti-LPF Serum to lnhibit the Mitogenic  Effects of PBM.  Because PBM  and 
LPF  were  separated  from  culture  supernatant  fluids  of B.  pertussis  by  molecular 
sieving, it was possible that PBM  was an aggregated form of LPF or that  it contained 
the mitogenic principle of LPF. Indeed Con A  and PHA, both T  mitogens, have been 
shown to stimulate B  lymphocytes when presented in insolubilized forms (22,  23).  To 
TABLE  IV 
Effect of T Cell Depletion on the Mitogenic Response of CBA/J Spleen Cells to PBM 
Treatment 
Mitogen/cuhure 
PBM, 0.25 #g  PBM, 0.5 #g  Con A, 0.5 p,g  LPS, 1.25 #g  None 
None  94.1 +  15.7"  91.3 +  16.2  99.3 ±  18.0  80.5 ±  8.9  3.4 +  0.4 
Anti-Thy-I plus GPC  73.9 ±  4.9  82.3 ±  3.3  0.4 ± 0  73.9 ±  8.4  0.6 ±  0.3 
Anti-Thy-1  91.2 ±  7.9  91.9 ±  1.4  91.1 ±  5.4  82.1 ±  14.8  ND 
GPC  75.4 ±  1.9  90.0 ±  14.2  56.4 ±  3.3  67.2 ±  4.0  ND 
CBA/J spleen cells were treated with Thy-1.2  antiserum and guinea pig complement (GPC) as described 
in Methods. Controls are spleen cells treated with either Thy 1.2 antiserum only or GPC only. ND, not 
done. 
* Counts per minute ×  10  -3 ±  SD of triplicate cultures of 5 ×  10  s lymphocytes at 48 h. 
TABLE  V 
PBM-induced Proliferation of Spleen Cells  from TxB Mice 
Mitogen 
Source of spleen cells 
CBA/J  TxB 
PBM, 0.5 #g  143.5 ±  3.6  113.1 +  6.7 
ConA, 0.5pg  130.9 ±  6.4  19.1:1:4.2 
LPS, 1.25 #g  124.3 ±  4.8  96.2 ±  2.8 
None  7.9 ±  2.4  5.6 ±  0.5 
TxB mice were 6-wk-old  CBA/J animals, which had  been adult  thymecto- 
mized, X-irradiated, and reconstituted with  14- to 16-d-old fetal  liver cells. 5 
×  10  s spleen cells from these mice were cultured in the presence of the indicated 
mitogens  for  48  h.  Controls  were  spleen  cells  from  normal  CBA/J  mice. 
Indicated are the mean counts per minute ×  10  -3 + SD of triplicate samples. 82  B  LYMPHOCYTE  MITOGEN FROM BORDETELLA  PERTUSSIS 
TABLE VI 
Effect of Macrophage Depletion on the Mitogenic Response of CBA/J Spleen Cells to PBM 
Experi-  Treatment 
ment 
Mitogen/culture 
PHA-P, 0.18 #1  Con A, 0.5 p.g  PBM, 0.5 btg  None 
cpm  X  I0 -a zl: SD 
1  None  21.8±2.7"  145.8:1=5.1  146.1±6.6  7.9±0.7 
G-10 column  28.3 ±  1.2  103.2 ± 8.8  166.5 ± 8.1  1.8 zt: 0.5 
2  None  ND  242.5 ± 21.2  131.7  ± 6.5  8.6 ±  1.7 
Carbonyl-iron  ND  206.3 ± 8.9  148.4 ±  16.8  2.1 ± 0.2 
* [aH]thymidine incorporation of 5 X  l0  n CBA/J spleen cells at 48 h. 
TABLE VII 
Failure of Monospecific Anti-LPF Serum to Inhibit PBM-induced Mitogenesis of CBA/J Spleen Cells 
Serum added per cul-  Mito~n_cultureCe/ 
ture 
LPF, 0.25 pg  I,PF, 0.5 pg  PBM, 0.25 #g  PBM, 0.5 #g  Con A, 0.5 #g  I,PS,  1.25 fig  None 
None  17.1±3.2  34.1"1"2.9  98.6:t:0.5  94.3±11.9  55.0±5.7  80.0±106  1.7±0. l 
Anti-LPF, 250 nl  3.5±0.8  6.5±0.3  95.4±2.2  109.6+4.0  55.8 ±  8.1  76.3± 1.9  4.4± 1.0 
Anti-LPF, 625 n[  3.6±0.2  3.6±0.7  97.6±6.0  110.8± 18.1  80.7±8.7  79.7±5.1  4.3 +  0.4 
Anti-LPF, 1,250 nl  ND  2.8 ±  0.6  NI)  87.9 ±  9.7  58.4 ±  2.4  77.4 ±  4.3  20 ±  0.3 
NRS, 250 nl  14.0± 1.5  26.7±2.6  106.8± 12.9  122.4+ 7.0  62.1  ±0.8  83.9± 7.4  2.8±0.4 
NRS, 625 nl  15.3 ±  2.8  44.2±6.0  120.4 ±  11.8  119.1 ±  9.9  89.6±6.9  82.9+0.7  3.5+0.3 
NRS,  1,250 nl  ND  37.5 ±  2.7  ND  90.2 ±  6.0  ND  NI)  4.8 +  1.7 
5X  10  CBA/J spleen cells were cultured in the absence or presence of indicated anaounts of mitogen and sera for 48 h. Indicated art, counts 
per minute ×  10  -~ ±  SD of triplicate cultures. ND, not done. 
test  whether  PBM  mitogenic  activity was  related  to  LPF,  monospecific  anti-LPF 
serum  (1) was added to PBM cultures (Table VII). It is clear that as little as 250 nl 
of anti-LPF  serum  totally  abolished  the  LPF  response,  but  failed  to  affect  PBM 
mitogenic activity. Similar findings were obtained when the concentration of antise- 
rum  was  increased  to  1,250  nl/culture.  Therefore,  it  appeared  that  the  mitogenic 
principle of PBM is distinct from that of LPF. 
Polyclonal  Activation  of CBA/J  Spleen  Lymphocytes  by PBM.  In  a  humoral  immune 
response, B  lymphocytes with specificity for the relevant antigen will proliferate and 
then differentiate to mature antibody-forming cells (AFC). After the activation of B 
lymphocytes by some mitogens, these cells not only undergo DNA synthesis but also 
produce and secrete antibodies of various specificities. These AFC can be detected by 
a  modified plaque  assay  (7).  When  spleen cells cultured  with  PBM  for 48  h  were 
recovered and assayed for AFC, it was found that cells secreting 19S IgM antibodies 
against sheep erythrocyte antigens and an unrelated hapten TNP were present (Table 
VIII). Therefore, PBM is also a  polyclonal activator of mouse B cells. 
Mitogenic Effects of PBM on HPBL.  To determine whether PBM is also a  mitogen 
for human lymphocytes, 0.125 X  106 HPBL were cultured with various concentrations 
of  PBM  in  0.25  ml.  These  culture  conditions  were  determined  by  preliminary 
experiments. Table IX shows  the  [3H]thymidine incorporation of HPBL  from  nine 
normal healthy adults in the presence of PBM.  All nine individuals were responsive 
to PBM;  the optimal mitogenic concentrations ranged from 2  to 5 #g/culture.  Most 
data  obtained  thus  far were  from  cultures  supplemented  with  5%  FC:S.  However, M.-K.  HO,  S.  I.  MORSE,  AND  A.  S.  KONG 
TABLE  VIII 
Polyclonal Activation of CBA/J Spleen Cells by PBM 
Mitogen/cul-  Viable cells re- 
ture  covered ×  106. 
Direct PFC/10 6 viable cells 
SRBC  TNP-SRBC 
PBM 
1 #g  6.4  21  582 
2 #g  6.9  25  532 
3 #g  5.4  34  753 
4/.tg  6.9  34  401 
LPS 
5 #g  5.3  38  776 
10 #g  6.2  20  766 
20/zg  5.5  38  648 
30/~g  8.6  37  507 
LPF 
1 #g  6.9  0  10 
2 #g  7.2  0  6 
5 #g  7.0  0  9 
None  4.8  2  56 
* Pooled from duplicate cultures containing  10 ×  106 spleen cells in  1 ml. 
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TABLE  IX 
Proliferation of Human Peripheral Blood Lymphocytes in Response to PBM 
Mitogcn/cul- 
ture 
C.S.  S.K  S.M.  J.B. 
PBM, 1.5 #g  72.8  ±  5.2:~  43.2 ±  3.4  ND  ND 
PBM, 2.0/tg  128.6  ±  9.2  80.7±  10.7  98.9±6.2  48.5±5.3 
PBM, 2.5/Lg  131.9  ±  9.4  82.4±3.2  NI)  63.8±11.7 
PBM, 5.0#g  ND  NI)  ND  72.2  ±  9.9 
ConA,  113.0±8.1  61.1  ±0.7  59.6±5.8  ND 
1.25/ag 
PHA-P,  203.1  ±2.4  131.4  +  5.4  225.9±  17.8  ND 
1.25 ~tl 
PWM,  ND  NI)  ND  91LI ±  10.8 
0.16#1 
PWM,  NI)  NI)  ND  86.7 ±  10.5 
0.31  /~1 
PWM,  ND  NI)  ND  711.9 ±  9.9 
0.63 #1 
[)onors 
J. G. 
N1) 
N1) 
107.9  ±  11).2 
ND 
ND 
216.6 ±  4.7 
NI) 
NI) 
47.1  +  7.4 
W.L.  M.H.  C.M.  C.M.* 
44.8 +  3.5  NI)  N1)  N1) 
58.8 ±  5.3  ND  29.6 ±  2.6  NI) 
90.0 ±  3.9  96.9 ±  9.4  81.6 ±  7.5  57.8 ±  4.5 
ND  NI)  81.7 ±  9.3  li2.9 ±  8. I 
76.(/±  11.0  73.8  :t: 6.2  ND  ND 
95.1  ±  4.9  147.0  ±  8.3  N1)  NI) 
ND  ND  82.9 ±  14.4  ND 
ND  NI)  87.0 +  1(I.4  105.3  ±  5.3 
NI)  ND  76.9 ±  4.t5  67.7 ±  5.5 
None  0.6±0.1  0.1  ±0  0.2"60  2.4±0.8  3.2±  1.1)  0.5±0.1  4.6±  1.5 
* Cuhurc supplcmcmed with 5~/~ pooled AB serum instead of 5~/, FCS. 
:~ Counts 10el minute ×  l0  : ±  SD of t  ipllcatc cultures containing  1.25  x  II)  ~ HPBI, in 0.25 ml at  121) h. ND, not done. 
1.2 +  1).7  0.6 -I- 1).3 
HPBL  were  also  responsive  when  cultured  in  the  presence  of 5%  pooled  human  AB 
serum.  Time-course  studies  showed  that  maximum  stimulation  occurred  after  4-6  d 
of culture.  Therefore,  all  cultures  were  harvested  at  120  h.  Studies  were  also  carried 
out to examine  the morphology  of HPBL  after stimulation  by optimal  concentrations 
of PBM  for 5  d.  When  examined  after Wright-Giemsa  staining,  40-55%  of the viable 
cells recovered  were  found  to be blast  cells. 
Proliferation of Human  Cord  Blood Lymphocytes  in Response  to PBM.  The  fact  that  all 84  B  LYMPHOCYTE  MITOGEN  FROM  BORDETELLA  PERTUSSIS 
normal  adults  tested  were  responsive to  the  in  vitro stimulation  by PBM  strongly 
suggested  that  PBM  was  a  nonspecific  mitogen.  To  study  further  this  notion,  the 
mitogenic effect of PBM on cord blood lymphocytes was examined. It was found that 
cord blood lymphocytes could be induced to proliferate by PBM (Table X). Therefore, 
it appears that the proliferation observed in PBM cultures is not a result of antigenic 
stimulation of presensitized lymphocytes but rather is caused by nonspecific activation 
of PBM. 
PBM is a Polyclonal  Activator of HPBL.  Because PBM-stimulated mouse B lympho- 
cytes produce polyclonal antibodies  in  vitro, the effect of PBM  on  HPBL antibody 
formation was examined. The detection of human plaque-forming cells (PFC)  after 
stimulated  by  PWM  have  been  well  studied  by Fauci  and  Pratt  (10).  Therefore, 
similar procedures were used  for PBM  cultures.  2  ×  106 HPBL were cultured  with 
various concentrations of PBM in media supplemented with  10% pooled AB serum. 
After 6 d of culture, the cells were recovered and assayed for antibodies against sheep 
red  blood  cells  (SRBC)  and  SRBC  coated with  TNP.  As  seen  in  Table XI,  these 
antibodies were secreted by PBM-cultured HPBL leading to plaque formation in the 
hemolytic  plaque  assay.  However,  PBM-induced  antibody  formation  differed  in 
several  aspects  form  the  mitogenic  stimulation  by  PBM.  Firstly,  a  much  higher 
concentration of PBM was required for polyclonal activation (ranging from 20 to 40 
#g/cuhure) as compared with that needed for proliferative responses (2-5/xg/culture). 
This may be,  in  part,  accounted  for by the difference in  cell  numbers  and  culture 
conditions in the two assay systems. Secondly, in contrast with proliferation, different 
individuals  vary  greatly  in  their  response  to  the  polyclonal  activation  by  PBM. 
Thirdly,  the range for optimal stimulation  of lymphocytes from a  given individual 
tend  to be much narrower in  the PFC  assay than  for [3H]thymidine incorporation. 
Lastly, maximum numbers of PFC were detected on day 6 of culture whereas little or 
no PFC could be found on days 5 or 7.  For proliferative responses even though the 
optimal culture period was usually 5 d;  the decrease in response on day 4 or 6, was 
not as marked as that in the PFC assay. 
Discussion 
In addition  to the T  cell mitogen,  LPF, culture  supernatant  fluids of phase I  B. 
pertussis also contains a mitogen and polyclonal activator for mouse B lymphocytes. It 
TABLE  X 
Mitogenic EffeCts of PBM on Cord Blood Lymphocytes 
Mitogen/culture  Counts per minute × 
10 -:j ±  SD* 
PBM, 2/~g  3.9 ±  0.9 
PBM, 3/tg  11.8 ±  0.8 
PBM, 4/Lg  36.0 +_ 5.0 
PBM, 5/Lg  59.2 ±  4.7 
Con A, 0.625/xg  48.9 :tz  1.6 
Con A,  1.25/~g  40.2 +  2.9 
PHA-P, 0.625/~1  115.8 +  6.4 
PHA-P,  1.25 ~1  98.7  +  9.2 
None  2.5 +  0.5 
* From triplicate cultures containing 2.5  ×  105 cord blood lymphocytes har- 
vested at  120 h. The culture medium was supplemented with 5% FCS. M.-K. HO,  S.  I.  MORSE, AND A.  S.  KONG 
TABLE XI 
Polyclonal Activation of Human Peripheral Blood Lymphocytes by PBM 
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Mitogen 
Donor 1  Donor 2  Donor 3 
Viable  TNP-  Viable  TNP-  Viable  SRBC  SRBC  SRBC 
SRBC  ceils re-  PFC/106  SRBC  cells re-  PFC/  PFC/  covered  cells re-  PFC/  PFC/  covered  106 cells  covered  106 cells  cells 
X 10  6.  10  6 cells  X 10  6  10  6 cells  ×  10  6 
PWM 
30 p,l  1.7  163  402  1.8  51  36  1.2  60 
20 ,u,l  2.1  150  192  1.4  98  179  1.0  0 
10 p.l  3.6  114  98  2.0  18  33  0.9  89 
5/,tl  3.4  122  122  1.8  134  150  1.4  0 
2.5 p,I  2.6  104  166  2.2  19  57  2.8  8 
1.25 u,I  1.6  60  217  2.2  65  73  2.9  0 
PBM 
70 p,g  1.4  20  15  0.7  24  7  1.6  3 
60 p,g  1.5  0  9  0.4  17  0  2.1  82 
50 p,g  1.6  4  4  0.8  5  8  1.4  90 
40 .u.g  1.1  8  55  0.8  22  22  0.8  0 
30/.tg  1.4  205  216  0.7  129  96  ND  ND 
20/,tg  1.7  192  273  0.6  155  79  ND  ND 
None  0.9  2  0  0.4  5  0  0.6  0 
* Pooled from triplicate cultures of 2 ×  106 HPBL in 1 ml at 120 h. ND, not done. 
is clear that only B cells will proliferate in response to this mitogen in vitro because 
>95% of the blast cells recovered from 48 h  cultures bear slg. Hence, this mitogen is 
termed the PBM. 
The responding B cells are adherent to nylon-wool. Moreover, they can proliferate 
in response to PBM in the absence T  ceils because (a)  spleen cells from nu÷/nu  + or 
TxB  mice are  responsive to  PBM,  and  (b)  pretreatment of spleen cells with Thy-1 
antiserum  and  complement  has  little  effect  on  their  PBM-induced  proliferation. 
Macrophages  also seem  to  play little role  in the  mitogenic effect  of PBM  because 
macrophage depletion by either passage through Sephadex G-10 or incubation with 
carbonyl iron fails to decrease the [3H]thymidine incorporation of PBM cultures. As 
in the case of many B cells mitogens (24-26), PBM also induces the differentiation of 
mouse  splenic B  cells  into  AFC.  However,  whether  this  property  of PBM  is  also 
completely independent of T  cells and macrophages is not certain. 
Thus far, all mouse strains tested, including germfree CD-1 animals, are responsive 
to PBM. Furthermore, HPBL from all donors as well as cord blood lymphocytes are 
induced to synthesize DNA by PBM. Therefore, PBM seems to activate lymphocytes 
nonspecifically. 
Despite the occurrence of both in the same protein peak excluded from Sephadex 
G-150, PBM and the HA of B. pertussis  seem to be associated with distinct moieties. 
It  is  possible  to  remove  all  the  HA  activity  by  extensive  adsorption  with  sheep 
erythrocyte stroma (ghost) without affecting the mitogenicity of the fraction (M. Ho. 
Unpublished observations.). Preliminary analysis by polyacrylamide gel electropho- 
resis (PAGE) in the presence of sodium dodecyl sulfate (SDS) and 2-mercaptoethanol 
(2-ME)  indicate that the excluded peak contains five major polypeptides. However, 
after adsorption with erythrocyte stroma, only two remained. Whether one or both 86  B LYMPHOCYTE MITOGEN FROM BORDETELLA PERTUSSIS 
these polypeptides or repeating units of them, are the mitogenic prinicple(s) of PBM 
is not known. 
It has been shown that Con A and PHA, though mitogenic for T  cells when soluble, 
are capable of stimulating B lymphocytes when presented in insoluble forms. (22, 23). 
Because LPF and PBM are isolated from culture supernatant  fluids of B. pertussis  by 
similar procedures,  it  is  conceivable that  the  B  cell  mitogenic  activity observed  is 
merely produced  by aggregates of LPF or a  complex containing  LPF components. 
Therefore, the effects of a  monospecific rabbit anti-LPF serum on PBM mitogenesis 
was explored. This antiserum failed to diminish the mitogenic activity of PBM even 
when used at five times the concentration required to block LPF-induced proliferation. 
Furthermore, double immunodiffusion studies employing both monospecific anti-LPF 
serum  and  a  heterospecific  antiserum  raised  against  killed  B.  pertussis  organisms 
indicate that LPF is immunologically distinct from PBM (data not shown). Moreover, 
SDS-PAGE of LPF in the presence of 2-ME shows four major polypeptides, none of 
which is found in the PBM fraction before or after adsorption with sheep erythrocyte 
stroma. 
There is ample evidence suggesting that the LPS of many Gram-negative bacteria 
is a  mitogen as well as polyclonal activator for mouse B lymphocytes. However, the 
mitogenic effect of PBM is not a  result of LPS contamination based on experiments 
with C3H/HeJ mice, a known low responder to the in vitro activation by LPS. Spleen 
cells  from  these  mice indeed  respond  poorly to  LPS  isolated  from  B.  pertussis  but 
proliferate normally in the presence of PBM. 
Preliminary  results  show  that  most  of the  blast  cells in  PBM  cultures  of HPBL 
possess intracellular Ig. However, more stringent cell fractionation and marker studies 
are required  before the nature of PBM-responsive cells are well defined. There is no 
doubt  that  at  least  some human  peripheral  B  cells are activated by PBM  because 
only  B  cells  can  be  induced  to  produce  antibody.  In  view  of the  fact  that  the 
stimulation of mouse B cells by PBM is independent  of T  cells or macrophages, this 
is  likely to be the case for human  B  lymphocytes also.  If this  notion  is confirmed, 
PBM can be an excellent probe for the evaluation of human B lymphocytes function 
because of the high [aH]thymidine incorporation and PBM cultures. Indeed, the level 
of incorporation  is much higher than that  induced  by the known specific human B 
cell mitogens, namely, Nocardia water-soluble mitogen (NWSM)  (27), and endotoxin 
protein  (EP)  isolated from Gram-negative bacteria  (28).  Both of these mitogens are 
also  polyclonal  activators  for human  B  cells.  However,  it  is  unlikely  that  PBM  is 
related to either of these substances. In the case of NWSM, extremely weak polyclonal- 
activating effects can be detected. Moreover, PBM differs from EP in several respects. 
Firstly, in contrast with PBM-induced mitogenesis, the proliferation of EP cultures of 
HPBL is totally suppressed by the presence of human AB serum. Secondly, the peak 
of EP responses is at day 3 whereas that for PBM is usually at day 5. Thirdly, much 
lower concentrations of PBM  are required  for the induction  of DNA synthesis  (2-5 
~g  of protein  per  culture)  as  compared  with  EP  (25-50  /xg/culture).  Lastly,  the 
mitogenic proteins in S. typhosa EP seem to have molecular weights lower than  17,000 
(29),  whereas  PBM  obtained  after  adsorption  with  sheep  erythrocyte  stroma  is 
comprised of two major polypeptides with  molecular weights of 18,500  and 58,000. 
However,  firm  conclusions  cannot  be drawn  until  a  comparison  is  made  between 
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B. pertussis  organisms are widely used as adjuvants in the production of IgG and 
IgM antibodies, reaginic antibody, and experimental allergic encephalomyelitis (re- 
viewed in reference 30). LPS of B. pertussis can probably account for some, but not all, 
of the adjuvant effects of the whole organism. Thus, LPF has been implicated as an 
adjuvant  for reaginic  antibody  formation  (31),  but  not  for other antibody classes. 
Dresser (32)  showed that at high doses of antigen, B. pertussis  caused an increase in 
IgM antibody production by acting directing on B  cells.  Because PBM can induce 
polyclonal IgM formation in vitro, it will be of interest to investigate its adjuvanticity 
both in vitro and in vivo. 
Summary 
Pertussis B  mitogen  (PBM),  isolated  from culture supernatant  fluids of BordeteUa 
pertussis,  is a  potent mitogen for mouse and human lymphocytes. In mice, >95% of 
the blast cells recovered from PBM cultures bear surface immunoglobulins. Therefore, 
PBM  seems to induce  proliferation  of mouse B  lymphocytes, but  not  T  cells.  The 
proliferative  response  observed  is  nonspecific  because  cells  from  all  mouse  strains 
tested, including  germfree animals, are responsive. Moreover, the mitogenic activity 
of PBM  is  independent  of T  lymphocytes, macrophages,  or  serum  factors.  When 
human peripheral blood or cord blood lymphocytes are cultured in the presence of 
PBM, a high level of thymidine incorporation by these cells is detected. Furthermore, 
PBM can induce polyclonal antibody formation by both mouse and human lympho- 
cytes. Despite similar methods of isolation, PBM is distinct  from the lymphocytosis- 
promoting factor of B. pertussis,  a previously described T  cell mitogen. 
Received  for publication 17 September 1980. 
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